Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Elaheh Ghovehoud"'
Autor:
Valentina Cecchinato, Veronica Martini, Edisa Pirani, Elaheh Ghovehoud, Mariagrazia Uguccioni
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Leukocyte trafficking is mainly governed by chemokines, chemotactic cytokines, which can be concomitantly produced in tissues during homeostatic conditions or inflammation. After the discovery and characterization of the individual chemokines, we and
Externí odkaz:
https://doaj.org/article/541ac245aa50409b947568e107ccba26
Autor:
Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, Akanksha A. Shanbhag, Milos Matkovic, Maira Biggiogero, Pier Andrea Maida, Jacques Moritz, Chiara Toscano, Elaheh Ghovehoud, Raffaello Furlan, Franca Barbic, Antonio Voza, Guendalina De Nadai, Carlo Cervia, Yves Zurbuchen, Patrick Taeschler, Lilly A. Murray, Gabriela Danelon-Sargenti, Simone Moro, Tao Gong, Pietro Piffaretti, Filippo Bianchini, Virginia Crivelli, Lucie Podešvová, Mattia Pedotti, David Jarrossay, Jacopo Sgrignani, Sylvia Thelen, Mario Uhr, Enos Bernasconi, Andri Rauch, Antonio Manzo, Adrian Ciurea, Marco B. L. Rocchi, Luca Varani, Bernhard Moser, Barbara Bottazzi, Marcus Thelen, Brian A. Fallon, Onur Boyman, Alberto Mantovani, Christian Garzoni, Alessandra Franzetti-Pellanda, Mariagrazia Uguccioni, Davide F. Robbiani
Publikováno v:
Muri, Jonathan; Cecchinato, Valentina; Cavalli, Andrea; Shanbhag, Akanksha A; Matkovic, Milos; Biggiogero, Maira; Maida, Pier Andrea; Moritz, Jacques; Toscano, Chiara; Ghovehoud, Elaheh; Furlan, Raffaello; Barbic, Franca; Voza, Antonio; De Nadai, Guendalina; Cervia, Carlo; Zurbuchen, Yves; Taeschler, Patrick; Murray, Lilly A; Danelon-Sargenti, Gabriela; Moro, Simone; ... (2023). Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nature immunology, 24(4), pp. 604-611. Nature Publishing Group 10.1038/s41590-023-01445-w
Infection with severe acute respiratory syndrome coronavirus 2 associates with diverse symptoms, which can persist for months. While antiviral antibodies are protective, those targeting interferons and other immune factors are associated with adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a0f8dec0174a4b1d7107ac5687cdb9f
Autor:
Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, Akanksha A. Shanbhag, Milos Matkovic, Maira Biggiogero, Pier Andrea Maida, Jacques Moritz, Chiara Toscano, Elaheh Ghovehoud, Raffaello Furlan, Franca Barbic, Antonio Voza, Guendalina De Nadai, Carlo Cervia, Yves Zurbuchen, Patrick Taeschler, Lilly A. Murray, Gabriela Danelon-Sargenti, Simone Moro, Tao Gong, Pietro Piffaretti, Filippo Bianchini, Virginia Crivelli, Lucie Podešvová, Mattia Pedotti, David Jarrossay, Jacopo Sgrignani, Sylvia Thelen, Mario Uhr, Enos Bernasconi, Andri Rauch, Antonio Manzo, Adrian Ciurea, Marco B.L. Rocchi, Luca Varani, Bernhard Moser, Barbara Bottazzi, Marcus Thelen, Brian A. Fallon, Onur Boyman, Alberto Mantovani, Christian Garzoni, Alessandra Franzetti-Pellanda, Mariagrazia Uguccioni, Davide F. Robbiani
Publikováno v:
bioRxiv
Infection by SARS-CoV-2 leads to diverse symptoms, which can persist for months. While antiviral antibodies are protective, those targeting interferons and other immune factors are associated with adverse COVID-19 outcomes. Instead, we discovered tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca04d395480f1e2dd56c6ba09c24dc0b
https://pubmed.ncbi.nlm.nih.gov/35664993
https://pubmed.ncbi.nlm.nih.gov/35664993
Autor:
Jafar Vatandoost, Shohreh Teimuri, Kamran Ghaedi, Aref Hosseini, Timothy L. Megraw, M. Etemadifar, Elaheh Ghovehoud, Mohammad Hossein Nasr Esfahani
Publikováno v:
IBRO Reports. 6:S377-S378
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0db7ae016bfca901cf91ee991051735e
https://doi.org/10.1016/j.ibror.2019.07.1200
https://doi.org/10.1016/j.ibror.2019.07.1200
Autor:
Cecchinato, Valentina, Martini, Veronica, Pirani, Edisa, Ghovehoud, Elaheh, Uguccioni, Mariagrazia
Publikováno v:
Frontiers in Immunology; 2023, p1-11, 11p